6918 Stock Overview
Aplus Biotechnology Corporation Limited engages in the development of orthopedic trauma medical equipment products.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Aplus Biotechnology Corporation Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$69.80 |
| 52 Week High | NT$70.30 |
| 52 Week Low | NT$41.05 |
| Beta | 0 |
| 1 Month Change | 35.01% |
| 3 Month Change | 39.32% |
| 1 Year Change | 55.80% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 39.60% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6918 | TW Medical Equipment | TW Market | |
|---|---|---|---|
| 7D | 15.9% | 3.0% | 4.0% |
| 1Y | 55.8% | 5.4% | 28.5% |
Return vs Industry: 6918 exceeded the TW Medical Equipment industry which returned 5.4% over the past year.
Return vs Market: 6918 exceeded the TW Market which returned 28.5% over the past year.
Price Volatility
| 6918 volatility | |
|---|---|
| 6918 Average Weekly Movement | 6.0% |
| Medical Equipment Industry Average Movement | 4.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in TW Market | 8.7% |
| 10% least volatile stocks in TW Market | 2.2% |
Stable Share Price: 6918's share price has been volatile over the past 3 months.
Volatility Over Time: 6918's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | n/a | www.aplusbio.com |
Aplus Biotechnology Corporation Limited engages in the development of orthopedic trauma medical equipment products. The company is based in New Taipei City, Taiwan.
Aplus Biotechnology Corporation Limited Fundamentals Summary
| 6918 fundamental statistics | |
|---|---|
| Market cap | NT$2.13b |
| Earnings (TTM) | NT$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs 6918 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6918 income statement (TTM) | |
|---|---|
| Revenue | NT$0 |
| Cost of Revenue | NT$0 |
| Gross Profit | NT$0 |
| Other Expenses | NT$0 |
| Earnings | NT$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did 6918 perform over the long term?
See historical performance and comparison